Time to Angiographic Reperfusion and Clinical Outcome after Acute Ischemic Stroke in the Interventional Management of Stroke Phase III (IMS III) Trial: A Validation Study

BACKGROUND: The IMS III Trial did not demonstrate clinical benefit of the endovascular approach compared to IV rt-PA alone for moderate or severe ischemic strokes (NIHSS≥8) enrolled within three hours of stroke onset. Late reperfusion of tissue that is no longer salvageable may be one explanation, a...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Khatri, Pooja, Yeatts, Sharon D., Mazighi, Mikael, Broderick, Joseph P., Liebeskind, David S., Demchuk, Andrew M., Amarenco, Pierre, Carrozzella, Janice, Spilker, Judith, Foster, Lydia D., Goyal, Mayank, Hill, Michael D., Palesch, Yuko Y., Jauch, Edward C., Haley, E. Clarke, Vagal, Achala, Tomsick, Thomas A.
Format: Artigo
Langue:Inglês
Publié: 2014
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4174410/
https://ncbi.nlm.nih.gov/pubmed/24784550
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1474-4422(14)70066-3
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires